`
`EXHIBIT 2
`
`
`
`DEFAULTUNITED STATES PATENT AND TRADEMARK OFFICE
`_____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________
`
`EDWARDS LIFESCIENCES CORPORATION, EDWARDS
`LIFESCIENCES LLC, AND EDWARDS LIFESCIENCES AG
`Petitioners
`
`v.
`
`BOSTON SCIENTIFIC SCIMED, INC.
`Patent Owner
`_____________
`
`Case IPR2017-00060
`Patent 8,992,608 B2
`_____________
`
`[PROPOSED] STIPULATED PROTECTIVE ORDER
`
`The following Standing Protective Order will be automatically entered into the
`
`proceeding upon the filing of a petition for review or institution of a derivation:
`
`Standing Protective Order
`
`Mail Stop PATENT BOARD
`
`
`
`Patent Trial and Appeal Board
`U.S. Patent & Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`
`
`This standing protective order governs the treatment and filing of
`
`confidential information, including documents and testimony.
`
`1.
`
`Petitioners Edwards Lifesciences Corporation and Edwards
`
`Lifesciences LLC (“Edwards”) and Patent Owner Boston Scientific Scimed, Inc.
`
`(“Boston Scientific”) are parties to a patent infringement action in the United
`
`States District Court for the District of Delaware captioned Boston Scientific
`
`Corp., et al. v. Edwards Lifesciences Corp., et al., No. 1:16-cv-275-SLR (the
`
`“Delaware Action”). A protective order was entered in the Delaware Action (the
`
`“Delaware Protective Order,” attached hereto as Appendix A) that provides for
`
`the protection of trade secret, proprietary, and other confidential research,
`
`development, financial, business, or commercial information. The protective order
`
`permits the parties to use information designated pursuant to the Delaware
`
`Protective Order as “CONFIDENTIAL,” “HIGHLY CONFIDENTIAL,” or
`
`“HIGHLY CONFIDENTIAL -- ATTORNEYS’ EYES ONLY” (collectively,
`
`“Confidential Information”) in inter partes review proceedings relating to the
`
`patents-in-suit, including U.S. Patent 8,992,608. Edwards and Boston Scientific
`
`intend to use such Confidential Information in this inter partes review proceeding
`
`and desire to protect such information to the same extent that such information is
`
`protected by the Delaware Protective Order and in accordance with the rules and
`
`guidelines issued by the Patent Trial and Appeal Board (the “Board”).
`
`1
`
`
`
`1.2. Any Confidential informationInformation that a party seeks to use from
`
`the Delaware Action for purposes of this proceeding shall be clearly marked
`
`“PROTECTIVE ORDER MATERIAL.” Confidential Information designated in
`
`the Delaware Action shall continue to be maintained with the original
`
`confidentiality designation and shall continue to be subject to the protections
`
`provided for in the Delaware Protective Order.
`
`2.3. Access to confidential informationConfidential Information, for purposes of
`
`this proceeding, is limited to the following individuals who have executed the
`
`acknowledgment appended to this order (including the acknowledgment that they
`
`are bound by the prosecution bar set forth in Paragraph 8 of the Delaware
`
`Protective Order and the other provisions of the Delaware Protective Order):
`
`(A)
`
`Parties. Persons who are owners of a patent involved in the
`
`proceeding and other persons who are named parties to the
`
`proceedingproceedings, subject to the restrictions in paragraph 3(E) below
`
`and only as permitted by the terms of the Delaware Protective Order.
`
`(B)
`
`Party Representatives. Representatives of record for a party in
`
`the proceeding and outside counsel of record in the Delaware Action who
`
`would be permitted access to Confidential Information under the Delaware
`
`Protective Order, but only as permitted by the terms of the Delaware
`
`Protective Order.
`
`2
`
`
`
`(C)
`
`Experts. Retained experts of a party in the proceeding or in the
`
`Delaware Action who further certify in the Acknowledgement that they are
`
`not a competitor to any party, or a consultant for, or employed by, such a
`
`competitor with respect to the subject matter of the proceeding.
`
`(D)
`
`In-house counsel. In-house counsel of a party. but only as
`
`permitted by the terms of the Delaware Protective Order.
`
`(E)
`
`Other Employees of a Party. Employees, consultants or other
`
`persons performing work for a party, other than in-house counsel and
`
`in-house counsel’’s support staff, who sign the Acknowledgement shall be
`
`extended access to confidential informationConfidential Information only upon
`
`agreement of the parties or by order of the Board upon a motion brought by
`
`the party seeking to disclose confidential informationConfidential Information
`
`to that person. The party opposing disclosure to that person shall have the
`
`burden of proving that such person should be restricted from access to
`
`confidential information.such information, except that, to the extent disclosure
`
`to that person would not be permitted under the terms of the Delaware
`
`Protective Order, the party seeking to expand disclosure to include that
`
`person shall bear the burden of proving that such person should be
`
`permitted access to such information.
`
`3
`
`
`
`(F)
`
`The Office. Employees and representatives of the Office who
`
`have a need for access to the confidential informationConfidential Information
`
`shall have such access without the requirement to sign an
`
`Acknowledgement. Such employees and representatives shall include the
`
`Director, members of the Board and their clerical staff, other support
`
`personnel, court reporters, and other persons acting on behalf of the Office.
`
`(G)
`
`Support Personnel. Administrative assistants, clerical staff,
`
`court reporters and other support personnel of the foregoing persons who
`
`are reasonably necessary to assist those persons in the proceeding shall not
`
`be required to sign an Acknowledgement, but shall be informed of the terms
`
`and requirements of the Protective Order by the person they are supporting
`
`who receives confidential informationConfidential Information.
`
`3.4. Persons receiving confidential informationConfidential Information shall
`
`use reasonable efforts to maintain the confidentiality of the information,
`
`including:
`
`(A)(A) Maintaining such information in a secure location to which
`
`persons not authorized to receive the information shall not have access;
`
`(B)
`
`Otherwise using reasonable efforts to maintain the
`
`confidentiality of the information, which efforts shall be no less rigorous
`
`4
`
`
`
`than those the recipient uses to maintain the confidentiality of information
`
`not received from the disclosing party;
`
`(C)
`
`Ensuring that support personnel of the recipient who have
`
`access to the confidential informationConfidential Information understand and
`
`abide by the obligation to maintain the confidentiality of information
`
`received that is designated as confidential; and
`
`(D)
`
`Limiting the copying of confidential informationConfidential
`
`Information to a reasonable number of copies needed for conduct of the
`
`proceeding and maintaining a record of the locations of such copies.
`
`4.5. Persons receiving confidential informationConfidential Information shall
`
`use the following procedures to maintain the confidentiality of the
`
`information:
`
`(A)(A) Documents and Information Filed With the Board.
`
`(i)(i) A party may file documents or information with the Board under
`
`seal, together with a non-confidential description of the nature of the
`
`confidential information that is under seal and the reasons why the
`
`information is confidential and should not be made available to the public.
`
`The submission shall be treated as confidential and remain under seal,
`
`unless, upon motion of a party and after a hearing on the issue, or sua
`
`5
`
`
`
`sponte, the Board determines that the documents or information do not to
`
`qualify for confidential treatment.
`
`(ii)(ii) Where confidentiality is alleged as to some but not all of the
`
`information submitted to the Board, the submitting party shall file
`
`confidential and non- confidential versions of its submission, together with
`
`a Motion to Seal the confidential version setting forth the reasons why the
`
`information redacted from the non-confidential version is confidential and
`
`should not be made available to the public. The nonconfidential version of
`
`the submission shall clearly indicate the locations of information that has
`
`been redacted. The confidential version of the submission shall be filed
`
`under seal. The redacted information shall remain under seal unless, upon
`
`motion of a party and after a hearing on the issue, or sua sponte, the Board
`
`determines that some or all of the redacted information does not qualify for
`
`confidential treatment.
`
`(B)(B) Documents and Information Exchanged Among the Parties.
`
`Information designated as confidentialConfidential Information that is
`
`disclosed to another party during discovery or other proceedings before the
`
`Board, and that was not previously designated in the Delaware Action, shall
`
`be clearly marked as “PROTECTIVE ORDER MATERIAL”,” shall retain
`
`6
`
`
`
`any original confidentiality designations from the Delaware Action, and
`
`shall be produced in a manner that maintains its confidentiality.
`
`(j)
`
`Standard Acknowledgement of Protective Order. The following form may be used
`
`to acknowledge a protective order and gain access to information covered by the protective
`
`order:6. The parties agree that Confidential Information will be used only in
`
`connection with this proceeding and for no other purpose, except as provided
`
`by the Delaware Protective Order, law or by the parties’ agreement.
`
`[CAPTION]SIGNATURE BLOCKS ON FOLLOWING PAGE]
`
`7
`
`
`
`/G
`
`regory S. Cordrey (Reg. No. 44,089)
`Brian P. Egan (Reg. No. (54,866)
`Catherine Nyarady (Reg. No. 42,042)
`
`Attorneys for Petitioners
`Edwards Lifesciences Corporation,
`Edwards Lifesciences LLC, and
`Edwards Lifesciences AG
`
`DATED: ___________ __, 2017
`
`/J
`
`ennifer A. Sklenar (Reg. No. 40,205)
`Wallace Wu (Reg. No. ______)
`ARNOLD & PORTER KAYE
`SCHOLER LLP
`777 S. Figueroa Street, 44th Floor
`Los Angeles, CA 90017-5844
`Tel:
`(213) 243-4000
`Fax: (213) 243-4199
`
`Attorneys for Patent Owner Boston
`Scientific Scimed, Inc.
`
`SO ORDERED this
`
`day of ______________, 2017.
`
`PATENT TRIAL AND APPEAL BOARD
`
`8
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________
`
`EDWARDS LIFESCIENCES CORPORATION, EDWARDS
`LIFESCIENCES LLC, AND EDWARDS LIFESCIENCES AG
`Petitioners
`
`v.
`
`BOSTON SCIENTIFIC SCIMED, INC.
`Patent Owner
`_____________
`
`Case IPR2017-00060
`Patent 8,992,608 B2
`_____________
`
`Standard Acknowledgment for Access to Protective Order Material
`
`I I, __________, affirm that I have read the Protective Order; that I will
`
`abide by its terms; that I will use the confidential information (including the prosecution
`
`bar set forth in Paragraph 8 of the Delaware Protective Order and the other
`
`provisions of the Delaware Protective Order); that I will use Confidential
`
`Information only in connection with this proceeding and for no other purpose; that
`
`I will only allow access to support staff who are reasonably necessary to assist me
`
`in this proceeding; that prior to any disclosure to such support staff I informed or
`
`will inform them of the requirements of the Protective Order; that I am personally
`
`1
`
`
`
`responsible for the requirements of the terms of the Protective Order and I agree to
`
`submit to the jurisdiction of the Office and the United States District Court for the
`
`Eastern District of Virginia for purposes of enforcing the terms of the Protective
`
`Order and providing remedies for its breach.
`
`[Signature]
`DATE:
`
`SIGNATURE:
`
`2
`
`